Takeda has partnered with China's Innovent Biologics for a pair of late-stage cancer therapies, in a deal that includes an ...

Invikafusp alfa demonstrated significant antitumor activity in TMB-H and MSI-H tumors resistant to immune checkpoint blockade, with ORRs ranging from 20.5% to 33.3%. The trial's safety profile was ...

Three months after two men died in jail isolation cells, lawyers in a class-action lawsuit against San Diego County and the Sheriff’s Office are asking a federal judge to limit how long people with ...

Novel combination including eftilagimod alfa (efti) in neoadjuvant setting drives 51.5% tumour hyalinization/fibrosis in patients with soft tissue sarcoma (pHigh level of tumour hyalinization/fibrosis ...

The collaboration combines Innovent's proven immuno-oncology ("IO") and antibody-drug conjugate ("ADC") R&D capability and Takeda's experience in ...

On Oct. 6, more than 51,000 teachers across Alberta walked off the job after months of failed negotiations between the ...

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a ...

Researchers at Karolinska Institutet have discovered how cells can adjust their gene activity to survive when oxygen runs low ...

The team used human stem cells to create embryo-like structures dubbed “hematoids” that mirror some features of early human ...

Patients with sickle cell disease and beta-thalassemia treated with exagamglogene autotemcel reported substantial and ...